A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus

Biochemical and Biophysical Research Communications

Volumn 395, Issue 1, 2010, Pages 87-92

  Fu, Yuan Hui ^a,b   He, Jin Sheng ^a,c   Wang, Xiao Bo ^c   Zheng, Xian Xian ^c   Wu, Qiang ^c   Xie, Can ^c   Zhang, Mei ^c   Wei, Wei ^c   Tang, Qian ^c   Song, Jing Dong ^b   Qu, Jian Guo ^b   Hong, Tao ^a,b  

^a BEIJING JIAOTONG UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Attenuated Salmonella typhimurium; Heterologous prime boost immunization; Human respiratory syncytial virus; Regime; Replication deficient adenoviral vector

Indexed keywords

ADENOVIRUS VECTOR; RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS INFECTION; VACCINATION; VIRUS INFECTION; ADENOVIRUS; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; GENE VECTOR; GENETICS; HUMAN; IMMUNIZATION; IMMUNOLOGY; LUNG; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SALMONELLA TYPHIMURIUM; VIROLOGY; VIRUS PNEUMONIA; VIRUS REPLICATION;

ADENOVIRIDAE; HUMAN RESPIRATORY SYNCYTIAL VIRUS; MUS; RICE STRIPE VIRUS; SALMONELLA TYPHIMURIUM;

ADENOVIRIDAE; ANIMALS; ANTIBODY FORMATION; FEMALE; GENETIC VECTORS; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION, SECONDARY; LUNG; MICE; MICE, INBRED BALB C; PNEUMONIA, VIRAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; SALMONELLA TYPHIMURIUM; VACCINATION; VIRUS REPLICATION;

EID: 77951892222     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.144     Document Type: Article

References (36)

1. P.L. Collins, J.E. Crowe Jr., Respiratory Syncytial Virus and Metapneumovirus, Lippincott Williams & Wilkins, a Wolters Kluwer Business, PA, 2007.
2. A.R. Falsey, Respiratory syncytial virus infection in elderly and high-risk adults, Exp. Lung Res. 31 (Suppl. 1) (2005) 77.
3. D. Qu, S. Wang, W. Cai, A. Du, Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice, Vaccine 26 (2008) 4541-4548.
4. C. Xie, J.S. He, M. Zhang, S.L. Xue, Q. Wu, X.D. Ding, W. Song, Y. Yuan, D.L. Li, X.X. Zheng, Y.Y. Lu, Z. Shang, Oral respiratory syncytial virus (RSV) DNA vaccine expressing RSV F protein delivered by attenuated Salmonella typhimurium, Hum. Gene Ther. 18 (2007) 746-752.
5. V.E. Sevil Domenech, K. Panthel, K.M. Meinel, S.E. Winter, H. Russmann, Preexisting anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis, Microbes Infect. 9 (2007) 1447-1453.
6. M.E. Gahan, D.E. Webster, O.L. Wijburg, S.L. Wesselingh, R.A. Strugnell, Impact of prior immunological exposure on vaccine delivery by Salmonella enterica serovar Typhimurium, Vaccine 26 (2008) 6212-6220.
7. W. Gao, A.C. Soloff, X. Lu, A. Montecalvo, D.C. Nguyen, Y. Matsuoka, P.D. Robbins, D.E. Swayne, R.O. Donis, J.M. Katz, S.M. Barratt-Boyes, A. Gambotto, Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization, J. Virol. 80 (2006) 1959-1964.
8. J.R. Yu, S. Kim, J.B. Lee, J. Chang, Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection, J. Virol. 82 (2008) 2350-2357.
9. Y. Fu, J. He, X. Zheng, Q. Wu, M. Zhang, X. Wang, Y. Wang, C. Xie, Q. Tang, W. Wei, M. Wang, J. Song, J. Qu, Y. Zhang, T. Hong, Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice, Biochem. Biophys. Res. Commun. 381 (2009) 528-532.
10. H.Y. Shao, S.L. Yu, C. Sia, Y. Chen, E. Chitra, I.H. Chen, N. Venkatesan, C.H. Leng, P. Chong, Y.H. Chow, Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses, Vaccine 27 (2009) 5460-5471.
11. Z.C. Hartman, D.M. Appledorn, A. Amalfitano, Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications, Virus Res. 132 (2008) 1-14.
12. R. Schirmbeck, J. Reimann, S. Kochanek, F. Kreppel, The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens, Mol. Ther. 16 (2008) 1609-1616.
13. K. Abel, L. Strelow, Y. Yue, M.K. Eberhardt, K.A. Schmidt, P.A. Barry, A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus, Vaccine 26 (2008) 6013-6025.
14. I.M. Belyakov, J.D. Ahlers, G.J. Nabel, B. Moss, J.A. Berzofsky, Generation of functionally active HIV-1 specific CD8(+) CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization, Virology 381 (2008) 106-115.
15. Y. Li, C.M. Stirling, M.S. Denyer, P. Hamblin, G. Hutchings, H.H. Takamatsu, P.V. Barnett, Dramatic improvement in FMD DNA vaccine efficacy and crossserotype antibody induction in pigs following a protein boost, Vaccine 26 [2008(] 2647-2656.
16. S. Khanam, P. Rajendra, N. Khanna, S. Swaminathan, An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes, BMC Biotechnol. 7 (2007) 10.
17. S.D. Perkins, L.M. O'Brien, R.J. Phillpotts, Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination, Vaccine 24 (2006) 3440-3445.
18. Y. Yuan, J.S. He, M. Zhang, W. Song, D.L. Li, J.M. Yu, B. Yang, Clone, construction, and expression of eukaryotic expression vector containing F gene of human respiratory syncytial virus subgroup A, Immunol. J. 22 (2006) 330-333.
19. Y. Fu, J. He, X. Zheng, Q. Wu, M. Zhang, X. Wang, Y. Wang, C. Xie, Q. Tang, W. Wei, M. Wang, J. Song, J. Qu, Y. Zhang, T. Hong, Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice, Biochem. Biophys. Res. Commun. 381 (2009) 528-532.
20. N. Ternette, B. Tippler, K. Uberla, T. Grunwald, Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus, Vaccine 25 (2007) 7271-7279.
21. Y.H. Fu, J.S. He, X.X. Zheng, X.B. Wang, C. Xie, C.X. Shi, M. Zhang, Q. Tang, W. Wei, J.G. Qu, T. Hong, Intranasal vaccination with a helper-dependent adenoviral vector enhances transgene-specific immune responses in BALB/c mice, Biochem. Biophys. Res. Commun. 391 (2010) 857-861.
22. D.L. Woodland, Jump-starting the immune system: prime-boosting comes of age, Trends Immunol. 25 (2004) 98-104.
23. V.G. Hemming, G.A. Prince, R.L. Horswood, W.J. London, B.R. Murphy, E.E. Walsh, G.W. Fischer, L.E. Weisman, P.A. Baron, R.M. Chanock, Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model, J. Infect. Dis. 152 (1985) 1083-1087.
24. G.A. Prince, V.G. Hemming, R.L. Horswood, R.M. Chanock, Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat, Virus Res. 3 (1985) 193-206.
25. L.E. Weisman, Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populations, Curr. Opin. Mol. Ther. 11 (2009) 208-218.
26. K. Abarca, E. Jung, P. Fernandez, L. Zhao, B. Harris, E.M. Connor, G.A. Losonsky, Safety, tolerability, pharmacokinetics, and immunogenicity of motavizumab, a humanized, enhanced-potency monoclonal antibody for the prevention of respiratory syncytial virus infection in at-risk children, Pediatr. Infect. Dis. J. 28 [2009(] 267-272.
27. H. Mok, S. Lee, T.J. Utley, B.E. Shepherd, V.V. Polosukhin, M.L. Collier, N.L. Davis, R.E. Johnston, J.E. Crowe Jr., Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats, J. Virol. 81 (2007) 13710-13722.
28. A. Lazar, N. Okabe, P.F. Wright, Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus, Infect. Immun. 27 (1980) 862-866.
29. M.B. Mazanec, C.S. Kaetzel, M.E. Lamm, D. Fletcher, J.G. Nedrud, Intracellular neutralization of virus by immunoglobulin A antibodies, Proc. Natl. Acad. Sci. USA 89 (1992) 6901-6905.
30. M. Bomsel, M. Heyman, H. Hocini, S. Lagaye, L. Belec, C. Dupont, C. Desgranges, Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM, Immunity 9 (1998) 277-287.
31. W.H. Alwan, F.M. Record, P.J. Openshaw, CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells, Clin. Exp. Immunol. 88 (1992) 527-536
32. P. Wong, E.G. Pamer, Feedback regulation of pathogen-specific T cell priming, Immunity 18 (2003) 499-511.
33. M.J. Estcourt, A.J. Ramsay, A. Brooks, S.A. Thomson, C.J. Medveckzy, I.A. Ramshaw, Prime-boost immunization generates a high frequency, highavidity CD8(+) cytotoxic T lymphocyte population, Int. Immunol. 14 (2002) 31-37.
34. S.M. Sumida, D.M. Truitt, A.A. Lemckert, R. Vogels, J.H. Custers, M.M. Addo, S. Lockman, T. Peter, F.W. Peyerl, M.G. Kishko, S.S. Jackson, D.A. Gorgone, M.A. Lifton, M. Essex, B.D. Walker, J. Goudsmit, M.J. Havenga, D.H. Barouch, Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein, J. Immunol. 174 [2005(] 7179-7185.
35. S.M. Sumida, D.M. Truitt, M.G. Kishko, J.C. Arthur, S.S. Jackson, D.A. Gorgone, M.A. Lifton, W. Koudstaal, M.G. Pau, S. Kostense, M.J. Havenga, J. Goudsmit, N.L. Letvin, D.H. Barouch, Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors, J. Virol. 78 [2004(] 2666-2673.
36. Z. Durrani, T.L. McInerney, L. McLain, T. Jones, T. Bellaby, F.R. Brennan, N.J. Dimmock, Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization, J. Immunol. Methods 220 (1998) 93-103.